Osborne Clarke has advised neuroClues®. neuroClues®, a European MedTech company powered by P3Lab SRL, has completed a €10 million Series A investment round. The funding round...
neuroClues® Secures €10 Million in Series A Fundraising for AI-Powered Neurological Biomarkers Expansion
Fortino Capital’s Investment in Addactis Group SA
Osborne Clarke advised Fortino Capital on the deal. Fortino Capital invested in Addactis to accelerate the growth of this specialist in actuarial B2B SaaS software. Addactis succesfully...
OncoDNA’s €6.5 Million Round C Financing
Osborne Clarke advised OncoDNA on the fundraising. OncoDNA announced its Round C financing of €6.5 million. Both private (including Vesalius BioCapital III, Ackermans & van Haaren,...
Sunrise’s €17 Million Fundraising
Osborne Clarke has advised Sunrise. Sunrise recently raised €17 million to support the roll out of their ground-breaking sleep research in Europe and the American market. Sunrise’s...